台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    62.7
  • 漲跌
    ▼0.9
  • 漲幅
    -1.42%
  • 成交量
    94
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-凱基-大直 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-大直 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/13162.8000.0062.7011410.71%
2024/11/08264.8000.0065.7021321.51%
2024/10/0800.00463.6063.20-4150-2.67%
2024/08/1200.000.256.5056.60-0.2201-0.10%
2024/08/07260.30161.7062.4011950.51%
2024/08/05159.0000.0057.9012080.48%
2024/07/29466.6000.0066.6042191.82%
2024/07/23261.5000.0061.4022190.91%
2024/06/0700.00166.5066.30-1217-0.46%
2024/06/06167.1000.0067.1012170.46%
2024/03/1200.001056.5958.10-10246-4.05%
2024/03/0400.00163.0061.10-1226-0.44%
2024/02/291063.60162.1063.6092204.07%
2024/02/27265.4500.0064.3022160.92%
2024/01/0300.000.151.3050.70-0.1419-0.02%
2023/12/260.151.5000.0050.400.14110.01%
2023/12/1300.00049.7049.1003930.00%
2023/11/17151.0000.0050.5013430.29%
2023/11/07456.30454.8057.9002560.00%
2023/11/06152.80354.6054.80-2209-0.96%
2023/11/03253.8000.0052.0021731.15%
2023/11/02249.80251.4051.0001160.00%
2023/11/0100.00150.0051.90-177-1.29%
2023/08/1000.00046.3046.30079-0.04%
2023/08/01148.1000.0048.401771.29%
2023/07/3100.00048.4048.40075-0.02%
2023/07/250.147.3000.0047.600.1720.08%
2023/07/2400.00048.1047.00072-0.01%
2023/07/19048.8000.0049.850620.03%
2022/12/0500.00147.1047.00-196-1.03%
2022/11/22145.3500.0044.4011530.65%
2022/09/3000.00143.3543.60-1304-0.33%
2022/09/1900.00548.6148.05-5288-1.73%
2022/09/13150.3000.0050.6012800.36%
2022/09/1200.00148.9049.30-1276-0.36%
2022/09/07648.8500.0048.8062722.20%
2022/07/29247.00245.0044.9501300.00%
2022/07/2600.00146.0545.90-198-1.01%
2022/07/25147.7500.0047.951801.24%
2022/04/2900.00043.5043.50050-0.04%
2022/04/2800.00043.1543.30050-0.06%
2022/04/1900.000.144.7544.90-0.146-0.21%
2022/04/180.244.3500.0045.250.2450.33%
2022/02/2100.00542.3242.20-538-13.04%
2021/11/1700.00643.7444.00-693-6.41%
2021/07/16141.5000.0041.4012270.44%
2021/07/12242.3500.0042.3522300.87%
2021/07/06343.5000.0043.4032331.28%
2021/05/17242.9500.0041.0521361.46%
2021/04/29246.00246.2046.0001150.00%
2019/08/2800.008.779.1279.80-8.741-21.07%
2019/08/1600.00179.6079.60-142-2.37%
2019/08/1400.00180.9080.00-142-2.34%
2019/08/0700.00175.4075.20-139-2.53%
2019/08/05174.8000.0074.801362.76%
2019/01/3000.00167.3065.90-148-2.05%
2019/01/23171.0000.0070.201432.30%
2018/08/30483.0000.0083.0041722.31%
2018/04/2700.00380.9380.10-3422-0.71%
2018/04/26292.05290.9089.0004090.00%
2018/04/25297.1000.0090.0023840.52%
2018/04/2400.00595.8093.30-5333-1.50%
2018/04/23693.1700.0093.8062982.01%
2018/04/1900.00184.3086.90-1266-0.38%
2018/04/18484.53483.5084.7002530.00%
2018/04/17179.2000.0081.1012440.41%
2018/04/1600.00180.3077.20-1232-0.43%
2018/04/09177.9000.0077.8011930.52%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章